Cancer-Myelodysplastic Syndromes (MDS) and Acute Myeloid Leukemia (AML)-Connect
| Title | Connect® MDS/AML: The Myelodysplastic Syndromes (MDS) and Acute Myeloid Leukemia (AML) Disease Registry |
|---|---|
| Description | This is an observational disease registry. Patients newly diagnosed with MDS or AML are asked to provide information by completing quality of life questionnaires that are administered at certain time points throughout the study. |
| NCT Number | 01688011 |
| Notes | Newly diagnosed MDS patients at least 18 years of age and newly diagnosed AML patients at least 55 years of age are eligible for the registry. Additional information is available on ClinicalTrials.gov |
| Status | Active; enrolling |
| Start Date | 03/30/2014 |
| Principal Name | Kerry Pulver, MD |
| Contact Name | Heather Webb, CCRC |
| Phone | (208) 367-6816 |